Gavin MacBeath is Chief Scientific Officer at TScan Therapeutics, Inc. (TCRX). They have made 1 open-market trade across 1 company since 2021, most recently 2021-09-21.
CIK 0001738082
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $31K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TCRX | 49,710 | $10K |
Shares reported on the most recent Form 4, priced at the 2021-09-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TCRX | BUY | 2021-09-20 | 2021-09-22 | $6.22 | $31K | +27.7% | +17.1% | -26.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.